Global Topical Drugs CDMO Market By Product Type (Semi-solid Formulations (Creams, Ointments, Gels, Other)semi-solid formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products) By Service (Contract Development, Contract Manufacturing) By Therapeutic Area (Dermatology, Pain management, Wound care, Ophthalmology, Other therapeutic areas) By End-use (Pharmaceutical Companies, Biopharmaceutical Companies, Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: April 2025
- Report ID: 145837
- Number of Pages: 249
- Format:
-
-
-
- Lubrizol Life Science
- Cambrex Corporation
- Ascendia Pharmaceuticals
- Pierre Fabre group
- MedPharm Ltd
- PCI Pharma Services
- Piramal Pharma Solutions
- DPT Laboratories, LTD
- Contract Pharmaceuticals Limited
- Bora Pharmaceutical CDMO
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |